Naloxone : actions of an antagonist
Dorp, E.L.A. van
Citation
Dorp, E. L. A. van. (2009, June 24). Naloxone : actions of an antagonist. Retrieved from https://hdl.handle.net/1887/13865
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/13865
Note: To cite this publication please use the final published version (if applicable).
Curriculum Vitae
Eveline Louise Arianna van Dorp was born on January 7th, 1982 in Leiden. She obtained her VWO (gymnasium) diploma at the Stedelijk Gymnasium Leiden in June 2000. Later that year she entered Medical School at the University of Utrecht. During her early clinical rotations, she became interested in anesthesiology and found a place as a data-management assistant for the peri-operative complication registration in the Leiden University Medical Center in 2003. In 2005, she became a PhD student at the Department of Anesthesiology in the Leiden University Medical Center and started the investigations described in this thesis. She transferred to Leiden University for the final year of Medical School and in June 2006, she received her Medical Degree from Leiden University. In June 2009, she hopes to start her residency in Anesthesiology in the Department of Anesthesiology, Leiden University Medical Center.
109
List of Publications
1. Van Dorp E and Smit R: ‘Softwarematige straaljagerpiloten.’ VPRO-Gids 30, 1999.
2. Van Dorp ELA, Romberg R, Sarton E, Bovill JG and Dahan A: ‘Morphine-6- glucuronide: morphine’s successor for postoperative pain relief?’ Anesth Analg, 102(6):1789–1797, 2006.
3. Van Dorp E, Yassen A, Sarton E, Romberg R, Olofsen E et al.: ‘Naloxone reversal of buprenorphine-induced respiratory depression.’ Anesthesiology, 105(1):51–57, 2006.
4. Romberg R, van Dorp E, Hollander J, Kruit M, Binning A et al.: ‘A randomized, double-blind, placebo-controlled pilot study of IV morphine-6-glucuronide for postoperative pain relief after knee replacement surgery.’ Clin J Pain, 23(3):197–
203, 2007.
5. Van Dorp ELA, Yassen A and Dahan A: ‘Naloxone treatment in opioid addiction:
the risks and benefits.’ Expert Opin Drug Saf, 6(2):125–132, 2007.
6. Van Dorp E, Los M, Dirven P, Sarton E, Valk P et al.: ‘Inspired carbon dioxide during hypoxia: effects on task performance and cerebral oxygen saturation.’
Aviat Space Environ Med, 78(7):666–672, 2007.
7. Yassen A, Olofsen E, van Dorp E, Sarton E, Teppema L et al.: ‘Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine- induced respiratory depression by naloxone : a study in healthy volunteers.’ Clin Pharmacokinet, 46(11):965–980, 2007.
8. Dahan A, van Dorp E, Smith T and Yassen A: ‘Morphine-6-glucuronide (M6G) for postoperative pain relief.’ Eur J Pain, 12(4):403–411, 2008.
9. Van Dorp ELA, Morariu A and Dahan A: ‘Morphine-6-glucuronide: potency and safety compared with morphine.’ Expert Opin Pharmacother, 9(11):1955–1961, 2008.
110
10. Teppema LJ, van Dorp E, Gourabi BM, van Kleef JW and Dahan A: ‘Differential effect of morphine and morphine-6-glucuronide on the control of breathing in the anesthetized cat.’ Anesthesiology, 109(4):689–697, 2008.
11. Van Dorp E, Kest B, Kowalczyk B, Morariu A, Waxman A et al.: ‘Morphine- 6-glucuronide induces hyperalgesic responses to experimental heat pain in mice and healthy volunteers.’ Anesthesiology, in press, 2009.
111
